ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 532

The Prevalance of Autoimmune Thyroid Disfunction in Ankylosing Spondylitis

Hakan Emmungil1, Mehmet Erdogan2, Melike Kalfa1, Gonca Karabulut1, Hayriye Kocanaogullari1, Vedat Inal1, Yasemin Kabasakal3, Fahrettin Oksel4, Kenan Aksu5 and Gokhan Keser6, 1Dept. of Internal Medicine, Division of Rheumatology, Ege University, Dept. of Internal Medicine, Division of Rheumatology, Ege University, Izmir, Turkey, 2Dept. of Internal Medicine, Division of Endocrinolgy, Ege University, Dept. of Internal Medicine, Division of Endocrinolgy, Ege University, Izmir, Turkey, 3Dept. of Internal Medicine, Division of Rheumatology, Ege University, Izmir, Turkey, 4Division of Rheumatology, Ege University, Izmir, Turkey, 5Dept. Of Internal Medicine, Division of Rheumatology, Ege University, Dept. Of Internal Medicine, Division of Rheumatology, Ege University, Izmir, Turkey, 6Dept. of Internal Medicine, Division of Rheumatology, Dept. of Internal Medicine, Division of Rheumatology, Ege University, Izmir, Turkey

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Ankylosing spondylitis (AS), autoantibodies, autoimmune diseases and ultrasound

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Spondylarthropathies and Psoriatic Arthritis: Clinical Aspects and Treatment

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Although the association of autoimmune thyroid dysfunction and primary Sjögren’s syndrome (SjS) is well known, it is less clear whether a similar relationship also exists between autoimmune thyroid dysfunction and ankylosing spondylitis (AS). Therefore, we aimed to define the frequency of autoimmune thyroid dysfunction in patients with AS, to find out whether the frequency was significantly different from the healthy controls.

Methods:

Eighty patients with AS (mean age: 40.57±10.13 years; M/F: 50/30) fulfilling the 1984 Modified New York Criteria and 80 healthy subjects, age and sex-matched with AS patients were included. As the positive control group, 62 female patients with primary SjS (mean age: 50.27± 10.84 years) fulfilling the diagnostic criteria of the European Consensus Group were also studied. All cases underwent thyroid ultrasonography by a single endocrinologist to evaluate the size, nodularity and homogeneity of the thyroid gland. Besides, serum free triiodothyronine (fT3), thyroxine (fT4), thyroid-stimulating hormone (TSH), and thyroid autoantibodies were measured. The diagnosis of Hashimoto’s thyroiditis was made only if the patient had thyroid autoantibody positivity plus at least one of the following criteria, namely diffuse goiter with physical examination, abnormality in thyroid function tests and ultrasonographic thyroid hypoechogenicity. Statistical analysis was performed with SPSS.15 for Windows. The chi-squared test and Fisher’s exact test, when appropriate, were used to compare cases and controls. p values < 0.05 were considered statistically significant.

Results:

The frequency of Hashimoto’s thyroiditis was significantly higher in patients with AS compared with age and sex-matched healthy controls (10% vs 1.3% p: 0.034). Similarly, the frequencies of any thyroid autoantibody positivity (13.8% vs 2.5% p: 0.017) and ultrasonographic thyroid hypoechogenicity (30% vs 11.3% p: 0.045) were also significantly higher in AS group. Other parameters such as thyroid gland volume and nodularity, and thyroid function tests did not differ significantly between AS and healthy control groups. As expected, frequencies of Hashimoto’s thyroiditis, thyroid autoantibodies and thyroid hypoechogenicity were highest in primary SjS group, however differences did not reach to statistically significant levels between the SjS and AS groups.

Conclusion:

The present study showed that the frequency of autoimmune thyroid dysfunction was significantly higher in AS group, compared with healthy controls. It should be kept in mind that, patients with AS may have concomitant autoimmune thyroid dysfunction, and in case of clinical suspicion, such patients should be further evaluated with clinical and laboratory parameters.


Disclosure:

H. Emmungil,
None;

M. Erdogan,
None;

M. Kalfa,
None;

G. Karabulut,
None;

H. Kocanaogullari,
None;

V. Inal,
None;

Y. Kabasakal,
None;

F. Oksel,
None;

K. Aksu,
None;

G. Keser,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-prevalance-of-autoimmune-thyroid-disfunction-in-ankylosing-spondylitis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology